RESUMENEl carcinoma basocelular es la neoplasia maligna más frecuente en el ser humano. Se caracteriza por ser localmente invasivo y de crecimiento lento. Presentamos el caso de un paciente con un carcinoma basocelular avanzado, que le causó una marcada destrucción de la región nasal y que por ello no fue susceptible de tratamiento quirúrgico o radioterapia. Para este tipo de pacientes se propone una nueva terapia innovadora, el Vismodegib, una molécula que inhibe la proliferación tumoral y que ha supuesto un gran avance en el manejo de estos pacientes.Palabras clave: Carcinoma basocelular. Destrucción cutánea. Vismodegib. Vía de señalización Hedgehog. ABSTRACT A highly destructive tumourThe basal-cell carcinoma is the most frequent cancer in human beings. It is characterized by being locally invasive and slow-growing. We present the case of a patient with basal cell carcinoma which caused a marked destruction of the nasal region, for which reason he could not be treated surgically or with radiotherapy. For this type of patient, a new innovative therapy is proposed: Vismodegib, a molecule which inhibits the spreading of the tumour and which has signified a great advance in the management of these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.